Positive Displacement Meter
Positive Displacement Meter market is segmented by Type and by Application. Players, stakeholders ... Read More
Global Plasma Derived Medicine Market Insights and Forecast to 2031
1 Study Coverage
1.1 Plasma Derived Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Plasma Derived Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Albumin
1.2.3 Coagulation Factor
1.2.4 Immunoglobulin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Plasma Derived Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Plasma Derived Medicine Sales Estimates and Forecasts 2017-2028
2.2 Global Plasma Derived Medicine Revenue Estimates and Forecasts 2017-2028
2.3 Global Plasma Derived Medicine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Plasma Derived Medicine Sales by Region
2.4.1 Global Plasma Derived Medicine Sales by Region (2017-2022)
2.4.2 Global Sales Plasma Derived Medicine by Region (2023-2028)
2.5 Global Plasma Derived Medicine Revenue by Region
2.5.1 Global Plasma Derived Medicine Revenue by Region (2017-2022)
2.5.2 Global Plasma Derived Medicine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Plasma Derived Medicine Sales by Manufacturers
3.1.1 Global Top Plasma Derived Medicine Manufacturers by Sales (2017-2022)
3.1.2 Global Plasma Derived Medicine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Plasma Derived Medicine in 2021
3.2 Global Plasma Derived Medicine Revenue by Manufacturers
3.2.1 Global Plasma Derived Medicine Revenue by Manufacturers (2017-2022)
3.2.2 Global Plasma Derived Medicine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Plasma Derived Medicine Revenue in 2021
3.3 Global Plasma Derived Medicine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Plasma Derived Medicine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Plasma Derived Medicine Sales by Type
4.1.1 Global Plasma Derived Medicine Historical Sales by Type (2017-2022)
4.1.2 Global Plasma Derived Medicine Forecasted Sales by Type (2023-2028)
4.1.3 Global Plasma Derived Medicine Sales Market Share by Type (2017-2028)
4.2 Global Plasma Derived Medicine Revenue by Type
4.2.1 Global Plasma Derived Medicine Historical Revenue by Type (2017-2022)
4.2.2 Global Plasma Derived Medicine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Plasma Derived Medicine Revenue Market Share by Type (2017-2028)
4.3 Global Plasma Derived Medicine Price by Type
4.3.1 Global Plasma Derived Medicine Price by Type (2017-2022)
4.3.2 Global Plasma Derived Medicine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Plasma Derived Medicine Sales by Application
5.1.1 Global Plasma Derived Medicine Historical Sales by Application (2017-2022)
5.1.2 Global Plasma Derived Medicine Forecasted Sales by Application (2023-2028)
5.1.3 Global Plasma Derived Medicine Sales Market Share by Application (2017-2028)
5.2 Global Plasma Derived Medicine Revenue by Application
5.2.1 Global Plasma Derived Medicine Historical Revenue by Application (2017-2022)
5.2.2 Global Plasma Derived Medicine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Plasma Derived Medicine Revenue Market Share by Application (2017-2028)
5.3 Global Plasma Derived Medicine Price by Application
5.3.1 Global Plasma Derived Medicine Price by Application (2017-2022)
5.3.2 Global Plasma Derived Medicine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Plasma Derived Medicine Market Size by Type
6.1.1 North America Plasma Derived Medicine Sales by Type (2017-2028)
6.1.2 North America Plasma Derived Medicine Revenue by Type (2017-2028)
6.2 North America Plasma Derived Medicine Market Size by Application
6.2.1 North America Plasma Derived Medicine Sales by Application (2017-2028)
6.2.2 North America Plasma Derived Medicine Revenue by Application (2017-2028)
6.3 North America Plasma Derived Medicine Market Size by Country
6.3.1 North America Plasma Derived Medicine Sales by Country (2017-2028)
6.3.2 North America Plasma Derived Medicine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
6.3.5 Mexico
7 Europe
7.1 Europe Plasma Derived Medicine Market Size by Type
7.1.1 Europe Plasma Derived Medicine Sales by Type (2017-2028)
7.1.2 Europe Plasma Derived Medicine Revenue by Type (2017-2028)
7.2 Europe Plasma Derived Medicine Market Size by Application
7.2.1 Europe Plasma Derived Medicine Sales by Application (2017-2028)
7.2.2 Europe Plasma Derived Medicine Revenue by Application (2017-2028)
7.3 Europe Plasma Derived Medicine Market Size by Country
7.3.1 Europe Plasma Derived Medicine Sales by Country (2017-2028)
7.3.2 Europe Plasma Derived Medicine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Plasma Derived Medicine Market Size by Type
8.1.1 Asia Pacific Plasma Derived Medicine Sales by Type (2017-2028)
8.1.2 Asia Pacific Plasma Derived Medicine Revenue by Type (2017-2028)
8.2 Asia Pacific Plasma Derived Medicine Market Size by Application
8.2.1 Asia Pacific Plasma Derived Medicine Sales by Application (2017-2028)
8.2.2 Asia Pacific Plasma Derived Medicine Revenue by Application (2017-2028)
8.3 Asia Pacific Plasma Derived Medicine Market Size by Region
8.3.1 Asia Pacific Plasma Derived Medicine Sales by Region (2017-2028)
8.3.2 Asia Pacific Plasma Derived Medicine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Indonesia
8.3.9 Thailand
8.3.10 Malaysia
8.3.11 Philippines
8.3.12 Vietnam
9 Latin America
9.1 Latin America Plasma Derived Medicine Market Size by Type
9.1.1 Latin America Plasma Derived Medicine Sales by Type (2017-2028)
9.1.2 Latin America Plasma Derived Medicine Revenue by Type (2017-2028)
9.2 Latin America Plasma Derived Medicine Market Size by Application
9.2.1 Latin America Plasma Derived Medicine Sales by Application (2017-2028)
9.2.2 Latin America Plasma Derived Medicine Revenue by Application (2017-2028)
9.3 Latin America Plasma Derived Medicine Market Size by Country
9.3.1 Latin America Plasma Derived Medicine Sales by Country (2017-2028)
9.3.2 Latin America Plasma Derived Medicine Revenue by Country (2017-2028)
9.3.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Plasma Derived Medicine Market Size by Type
10.1.1 Middle East and Africa Plasma Derived Medicine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Plasma Derived Medicine Revenue by Type (2017-2028)
10.2 Middle East and Africa Plasma Derived Medicine Market Size by Application
10.2.1 Middle East and Africa Plasma Derived Medicine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Plasma Derived Medicine Revenue by Application (2017-2028)
10.3 Middle East and Africa Plasma Derived Medicine Market Size by Country
10.3.1 Middle East and Africa Plasma Derived Medicine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Plasma Derived Medicine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 GCC Countries
10.3.6 South Africa
11 Company Profiles
11.1 Grifols
11.1.1 Grifols Corporation Information
11.1.2 Grifols Overview
11.1.3 Grifols Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Grifols Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Grifols Recent Developments
11.2 SK Plasma
11.2.1 SK Plasma Corporation Information
11.2.2 SK Plasma Overview
11.2.3 SK Plasma Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 SK Plasma Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 SK Plasma Recent Developments
11.3 Fusion Health Care
11.3.1 Fusion Health Care Corporation Information
11.3.2 Fusion Health Care Overview
11.3.3 Fusion Health Care Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Fusion Health Care Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fusion Health Care Recent Developments
11.4 Biotest AG
11.4.1 Biotest AG Corporation Information
11.4.2 Biotest AG Overview
11.4.3 Biotest AG Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Biotest AG Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biotest AG Recent Developments
11.5 GC Pharma
11.5.1 GC Pharma Corporation Information
11.5.2 GC Pharma Overview
11.5.3 GC Pharma Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GC Pharma Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GC Pharma Recent Developments
11.6 Baxter International
11.6.1 Baxter International Corporation Information
11.6.2 Baxter International Overview
11.6.3 Baxter International Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Baxter International Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Baxter International Recent Developments
11.7 LFB
11.7.1 LFB Corporation Information
11.7.2 LFB Overview
11.7.3 LFB Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 LFB Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 LFB Recent Developments
11.8 Octapharma AG
11.8.1 Octapharma AG Corporation Information
11.8.2 Octapharma AG Overview
11.8.3 Octapharma AG Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Octapharma AG Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Octapharma AG Recent Developments
11.9 CSL Limited
11.9.1 CSL Limited Corporation Information
11.9.2 CSL Limited Overview
11.9.3 CSL Limited Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 CSL Limited Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 CSL Limited Recent Developments
11.10 BPL
11.10.1 BPL Corporation Information
11.10.2 BPL Overview
11.10.3 BPL Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 BPL Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 BPL Recent Developments
11.11 China Biologic Products
11.11.1 China Biologic Products Corporation Information
11.11.2 China Biologic Products Overview
11.11.3 China Biologic Products Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 China Biologic Products Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 China Biologic Products Recent Developments
11.12 Kedrion Biopharma
11.12.1 Kedrion Biopharma Corporation Information
11.12.2 Kedrion Biopharma Overview
11.12.3 Kedrion Biopharma Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Kedrion Biopharma Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Kedrion Biopharma Recent Developments
11.13 RAAS
11.13.1 RAAS Corporation Information
11.13.2 RAAS Overview
11.13.3 RAAS Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 RAAS Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 RAAS Recent Developments
11.14 Tiantan Bio
11.14.1 Tiantan Bio Corporation Information
11.14.2 Tiantan Bio Overview
11.14.3 Tiantan Bio Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Tiantan Bio Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Tiantan Bio Recent Developments
11.15 Hualan Biological Engineering
11.15.1 Hualan Biological Engineering Corporation Information
11.15.2 Hualan Biological Engineering Overview
11.15.3 Hualan Biological Engineering Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Hualan Biological Engineering Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Hualan Biological Engineering Recent Developments
11.16 BOYA Bio-Pharmaceutical
11.16.1 BOYA Bio-Pharmaceutical Corporation Information
11.16.2 BOYA Bio-Pharmaceutical Overview
11.16.3 BOYA Bio-Pharmaceutical Plasma Derived Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 BOYA Bio-Pharmaceutical Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 BOYA Bio-Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Plasma Derived Medicine Industry Chain Analysis
12.2 Plasma Derived Medicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Plasma Derived Medicine Production Mode & Process
12.4 Plasma Derived Medicine Sales and Marketing
12.4.1 Plasma Derived Medicine Sales Channels
12.4.2 Plasma Derived Medicine Distributors
12.5 Plasma Derived Medicine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Plasma Derived Medicine Industry Trends
13.2 Plasma Derived Medicine Market Drivers
13.3 Plasma Derived Medicine Market Challenges
13.4 Plasma Derived Medicine Market Restraints
14 Key Findings in The Global Plasma Derived Medicine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Plasma Derived Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Albumin
Table 3. Major Manufacturers of Coagulation Factor
Table 4. Major Manufacturers of Immunoglobulin
Table 5. Major Manufacturers of Others
Table 6. Global Plasma Derived Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Plasma Derived Medicine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Plasma Derived Medicine Sales by Region (2017-2022) & (K MT)
Table 9. Global Plasma Derived Medicine Sales Market Share by Region (2017-2022)
Table 10. Global Plasma Derived Medicine Sales by Region (2023-2028) & (K MT)
Table 11. Global Plasma Derived Medicine Sales Market Share by Region (2023-2028)
Table 12. Global Plasma Derived Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Plasma Derived Medicine Revenue Market Share by Region (2017-2022)
Table 14. Global Plasma Derived Medicine Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Plasma Derived Medicine Revenue Market Share by Region (2023-2028)
Table 16. Global Plasma Derived Medicine Sales by Manufacturers (2017-2022) & (K MT)
Table 17. Global Plasma Derived Medicine Sales Share by Manufacturers (2017-2022)
Table 18. Global Plasma Derived Medicine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Plasma Derived Medicine Revenue Share by Manufacturers (2017-2022)
Table 20. Plasma Derived Medicine Price by Manufacturers (2017-2022) &(USD/MT)
Table 21. Global Plasma Derived Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Plasma Derived Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Derived Medicine as of 2021)
Table 23. Plasma Derived Medicine Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Plasma Derived Medicine Product Offered
Table 25. Date of Manufacturers Enter into Plasma Derived Medicine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Plasma Derived Medicine Sales by Type (2017-2022) & (K MT)
Table 28. Global Plasma Derived Medicine Sales by Type (2023-2028) & (K MT)
Table 29. Global Plasma Derived Medicine Sales Share by Type (2017-2022)
Table 30. Global Plasma Derived Medicine Sales Share by Type (2023-2028)
Table 31. Global Plasma Derived Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Plasma Derived Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Plasma Derived Medicine Revenue Share by Type (2017-2022)
Table 34. Global Plasma Derived Medicine Revenue Share by Type (2023-2028)
Table 35. Plasma Derived Medicine Price by Type (2017-2022) & (USD/MT)
Table 36. Global Plasma Derived Medicine Price Forecast by Type (2023-2028) & (USD/MT)
Table 37. Global Plasma Derived Medicine Sales by Application (2017-2022) & (K MT)
Table 38. Global Plasma Derived Medicine Sales by Application (2023-2028) & (K MT)
Table 39. Global Plasma Derived Medicine Sales Share by Application (2017-2022)
Table 40. Global Plasma Derived Medicine Sales Share by Application (2023-2028)
Table 41. Global Plasma Derived Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Plasma Derived Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Plasma Derived Medicine Revenue Share by Application (2017-2022)
Table 44. Global Plasma Derived Medicine Revenue Share by Application (2023-2028)
Table 45. Plasma Derived Medicine Price by Application (2017-2022) & (USD/MT)
Table 46. Global Plasma Derived Medicine Price Forecast by Application (2023-2028) & (USD/MT)
Table 47. North America Plasma Derived Medicine Sales by Type (2017-2022) & (K MT)
Table 48. North America Plasma Derived Medicine Sales by Type (2023-2028) & (K MT)
Table 49. North America Plasma Derived Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Plasma Derived Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Plasma Derived Medicine Sales by Application (2017-2022) & (K MT)
Table 52. North America Plasma Derived Medicine Sales by Application (2023-2028) & (K MT)
Table 53. North America Plasma Derived Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Plasma Derived Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Plasma Derived Medicine Sales by Country (2017-2022) & (K MT)
Table 56. North America Plasma Derived Medicine Sales by Country (2023-2028) & (K MT)
Table 57. North America Plasma Derived Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Plasma Derived Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Plasma Derived Medicine Sales by Type (2017-2022) & (K MT)
Table 60. Europe Plasma Derived Medicine Sales by Type (2023-2028) & (K MT)
Table 61. Europe Plasma Derived Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Plasma Derived Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Plasma Derived Medicine Sales by Application (2017-2022) & (K MT)
Table 64. Europe Plasma Derived Medicine Sales by Application (2023-2028) & (K MT)
Table 65. Europe Plasma Derived Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Plasma Derived Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Plasma Derived Medicine Sales by Country (2017-2022) & (K MT)
Table 68. Europe Plasma Derived Medicine Sales by Country (2023-2028) & (K MT)
Table 69. Europe Plasma Derived Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Plasma Derived Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Plasma Derived Medicine Sales by Type (2017-2022) & (K MT)
Table 72. Asia Pacific Plasma Derived Medicine Sales by Type (2023-2028) & (K MT)
Table 73. Asia Pacific Plasma Derived Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Plasma Derived Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Plasma Derived Medicine Sales by Application (2017-2022) & (K MT)
Table 76. Asia Pacific Plasma Derived Medicine Sales by Application (2023-2028) & (K MT)
Table 77. Asia Pacific Plasma Derived Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Plasma Derived Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Plasma Derived Medicine Sales by Region (2017-2022) & (K MT)
Table 80. Asia Pacific Plasma Derived Medicine Sales by Region (2023-2028) & (K MT)
Table 81. Asia Pacific Plasma Derived Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Plasma Derived Medicine Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Plasma Derived Medicine Sales by Type (2017-2022) & (K MT)
Table 84. Latin America Plasma Derived Medicine Sales by Type (2023-2028) & (K MT)
Table 85. Latin America Plasma Derived Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Plasma Derived Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Plasma Derived Medicine Sales by Application (2017-2022) & (K MT)
Table 88. Latin America Plasma Derived Medicine Sales by Application (2023-2028) & (K MT)
Table 89. Latin America Plasma Derived Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Plasma Derived Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Plasma Derived Medicine Sales by Country (2017-2022) & (K MT)
Table 92. Latin America Plasma Derived Medicine Sales by Country (2023-2028) & (K MT)
Table 93. Latin America Plasma Derived Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Plasma Derived Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Plasma Derived Medicine Sales by Type (2017-2022) & (K MT)
Table 96. Middle East and Africa Plasma Derived Medicine Sales by Type (2023-2028) & (K MT)
Table 97. Middle East and Africa Plasma Derived Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Plasma Derived Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Plasma Derived Medicine Sales by Application (2017-2022) & (K MT)
Table 100. Middle East and Africa Plasma Derived Medicine Sales by Application (2023-2028) & (K MT)
Table 101. Middle East and Africa Plasma Derived Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Plasma Derived Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Plasma Derived Medicine Sales by Country (2017-2022) & (K MT)
Table 104. Middle East and Africa Plasma Derived Medicine Sales by Country (2023-2028) & (K MT)
Table 105. Middle East and Africa Plasma Derived Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Plasma Derived Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 107. Grifols Corporation Information
Table 108. Grifols Description and Major Businesses
Table 109. Grifols Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 110. Grifols Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Grifols Recent Developments
Table 112. SK Plasma Corporation Information
Table 113. SK Plasma Description and Major Businesses
Table 114. SK Plasma Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 115. SK Plasma Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. SK Plasma Recent Developments
Table 117. Fusion Health Care Corporation Information
Table 118. Fusion Health Care Description and Major Businesses
Table 119. Fusion Health Care Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 120. Fusion Health Care Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Fusion Health Care Recent Developments
Table 122. Biotest AG Corporation Information
Table 123. Biotest AG Description and Major Businesses
Table 124. Biotest AG Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 125. Biotest AG Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Biotest AG Recent Developments
Table 127. GC Pharma Corporation Information
Table 128. GC Pharma Description and Major Businesses
Table 129. GC Pharma Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 130. GC Pharma Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. GC Pharma Recent Developments
Table 132. Baxter International Corporation Information
Table 133. Baxter International Description and Major Businesses
Table 134. Baxter International Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 135. Baxter International Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Baxter International Recent Developments
Table 137. LFB Corporation Information
Table 138. LFB Description and Major Businesses
Table 139. LFB Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 140. LFB Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. LFB Recent Developments
Table 142. Octapharma AG Corporation Information
Table 143. Octapharma AG Description and Major Businesses
Table 144. Octapharma AG Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 145. Octapharma AG Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Octapharma AG Recent Developments
Table 147. CSL Limited Corporation Information
Table 148. CSL Limited Description and Major Businesses
Table 149. CSL Limited Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 150. CSL Limited Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. CSL Limited Recent Developments
Table 152. BPL Corporation Information
Table 153. BPL Description and Major Businesses
Table 154. BPL Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 155. BPL Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. BPL Recent Developments
Table 157. China Biologic Products Corporation Information
Table 158. China Biologic Products Description and Major Businesses
Table 159. China Biologic Products Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 160. China Biologic Products Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. China Biologic Products Recent Developments
Table 162. Kedrion Biopharma Corporation Information
Table 163. Kedrion Biopharma Description and Major Businesses
Table 164. Kedrion Biopharma Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 165. Kedrion Biopharma Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Kedrion Biopharma Recent Developments
Table 167. RAAS Corporation Information
Table 168. RAAS Description and Major Businesses
Table 169. RAAS Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 170. RAAS Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. RAAS Recent Developments
Table 172. Tiantan Bio Corporation Information
Table 173. Tiantan Bio Description and Major Businesses
Table 174. Tiantan Bio Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 175. Tiantan Bio Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Tiantan Bio Recent Developments
Table 177. Hualan Biological Engineering Corporation Information
Table 178. Hualan Biological Engineering Description and Major Businesses
Table 179. Hualan Biological Engineering Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 180. Hualan Biological Engineering Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Hualan Biological Engineering Recent Developments
Table 182. BOYA Bio-Pharmaceutical Corporation Information
Table 183. BOYA Bio-Pharmaceutical Description and Major Businesses
Table 184. BOYA Bio-Pharmaceutical Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 185. BOYA Bio-Pharmaceutical Plasma Derived Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. BOYA Bio-Pharmaceutical Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Plasma Derived Medicine Distributors List
Table 190. Plasma Derived Medicine Customers List
Table 191. Plasma Derived Medicine Market Trends
Table 192. Plasma Derived Medicine Market Drivers
Table 193. Plasma Derived Medicine Market Challenges
Table 194. Plasma Derived Medicine Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Plasma Derived Medicine Product Picture
Figure 3. Global Plasma Derived Medicine Market Share by Type in 2021 & 2028
Figure 3. Albumin Product Picture
Figure 4. Coagulation Factor Product Picture
Figure 5. Immunoglobulin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Plasma Derived Medicine Market Share by Application in 2021 & 2028
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Other
Figure 11. Plasma Derived Medicine Report Years Considered
Figure 12. Global Plasma Derived Medicine Sales 2017-2028 (K MT)
Figure 13. Global Plasma Derived Medicine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Plasma Derived Medicine Revenue 2017-2028 (US$ Million)
Figure 15. Global Plasma Derived Medicine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Plasma Derived Medicine Sales Market Share by Region (2017-2022)
Figure 17. Global Plasma Derived Medicine Sales Market Share by Region (2023-2028)
Figure 18. North America Plasma Derived Medicine Sales YoY (2017-2028) & (K MT)
Figure 19. North America Plasma Derived Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Plasma Derived Medicine Sales YoY (2017-2028) & (K MT)
Figure 21. Europe Plasma Derived Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Plasma Derived Medicine Sales YoY (2017-2028) & (K MT)
Figure 23. Asia-Pacific Plasma Derived Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Plasma Derived Medicine Sales YoY (2017-2028) & (K MT)
Figure 25. Latin America Plasma Derived Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Plasma Derived Medicine Sales YoY (2017-2028) & (K MT)
Figure 27. Middle East & Africa Plasma Derived Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Plasma Derived Medicine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Plasma Derived Medicine in the World: Market Share by Plasma Derived Medicine Revenue in 2021
Figure 30. Global Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Plasma Derived Medicine Sales Market Share by Type (2017-2028)
Figure 32. Global Plasma Derived Medicine Revenue Market Share by Type (2017-2028)
Figure 33. Global Plasma Derived Medicine Sales Market Share by Application (2017-2028)
Figure 34. Global Plasma Derived Medicine Revenue Market Share by Application (2017-2028)
Figure 35. North America Plasma Derived Medicine Sales Market Share by Type (2017-2028)
Figure 36. North America Plasma Derived Medicine Revenue Market Share by Type (2017-2028)
Figure 37. North America Plasma Derived Medicine Sales Market Share by Application (2017-2028)
Figure 38. North America Plasma Derived Medicine Revenue Market Share by Application (2017-2028)
Figure 39. North America Plasma Derived Medicine Sales Share by Country (2017-2028)
Figure 40. North America Plasma Derived Medicine Revenue Share by Country (2017-2028)
Figure 41. United States Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 43. Mexico Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Plasma Derived Medicine Sales Market Share by Type (2017-2028)
Figure 45. Europe Plasma Derived Medicine Revenue Market Share by Type (2017-2028)
Figure 46. Europe Plasma Derived Medicine Sales Market Share by Application (2017-2028)
Figure 47. Europe Plasma Derived Medicine Revenue Market Share by Application (2017-2028)
Figure 48. Europe Plasma Derived Medicine Sales Share by Country (2017-2028)
Figure 49. Europe Plasma Derived Medicine Revenue Share by Country (2017-2028)
Figure 50. Germany Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 51. France Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 52. UK Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Plasma Derived Medicine Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Plasma Derived Medicine Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Plasma Derived Medicine Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Plasma Derived Medicine Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Plasma Derived Medicine Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Plasma Derived Medicine Revenue Share by Region (2017-2028)
Figure 61. China Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 64. India Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 70. Vietnam Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Plasma Derived Medicine Sales Market Share by Type (2017-2028)
Figure 72. Latin America Plasma Derived Medicine Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Plasma Derived Medicine Sales Market Share by Application (2017-2028)
Figure 74. Latin America Plasma Derived Medicine Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Plasma Derived Medicine Sales Share by Country (2017-2028)
Figure 76. Latin America Plasma Derived Medicine Revenue Share by Country (2017-2028)
Figure 77. Brazil Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Plasma Derived Medicine Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Plasma Derived Medicine Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Plasma Derived Medicine Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Plasma Derived Medicine Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Plasma Derived Medicine Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Plasma Derived Medicine Revenue Share by Country (2017-2028)
Figure 84. Turkey Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 85. GCC Countries Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 86. Egypt Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 87. South Africa Plasma Derived Medicine Revenue (2017-2028) & (US$ Million)
Figure 88. Plasma Derived Medicine Value Chain
Figure 89. Plasma Derived Medicine Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Grifols SK Plasma Fusion Health Care Biotest AG GC Pharma Baxter International LFB Octapharma AG CSL Limited BPL China Biologic Products Kedrion Biopharma RAAS Tiantan Bio Hualan Biological Engineering BOYA Bio-Pharmaceutical